NasdaqCM - Nasdaq Real Time Price USD
BioRestorative Therapies, Inc. (BRTX)
1.7300
+0.0100
+(0.58%)
At close: April 23 at 4:00:02 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-8,230.3460
-8,230.3460
--
-5,913.1000
-3,329.9080
Investing Cash Flow
514.5290
514.5290
--
-13,399.8550
-30.6580
Financing Cash Flow
7,379.3300
7,379.3300
2,348.7730
--
21,322.6830
End Cash Position
547.8900
547.8900
884.3770
1,713.7720
21,026.7270
Capital Expenditure
-106.1890
-106.1890
--
-440.2230
-30.6580
Issuance of Capital Stock
--
--
2,348.7730
--
21,072.6830
Issuance of Debt
--
--
--
--
250
Free Cash Flow
-8,336.5350
-8,336.5350
--
-6,353.3230
-3,360.5660
12/31/2021 - 12/5/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MBIO Mustang Bio, Inc.
1.3294
+3.86%
CELZ Creative Medical Technology Holdings, Inc.
1.9700
-1.50%
TSOI Therapeutic Solutions International, Inc.
0.0002
0.00%
RDTCF Rapid Dose Therapeutics Corp.
0.0080
0.00%
RMTG Regenerative Medical Technology Group Inc.
0.0390
0.00%
RGBPP Regen BioPharma, Inc.
0.0581
0.00%
ASEP.CN ASEP Medical Holdings Inc.
0.5000
0.00%
TELI.CN Telescope Innovations Corp.
0.2600
-10.34%
MBX.TO Microbix Biosystems Inc.
0.3550
+1.43%
GLOW.CN Glow Lifetech Corp.
0.0600
0.00%